251 related articles for article (PubMed ID: 2252337)
1. Serotonin and migraine.
Humphrey PP; Feniuk W; Perren MJ; Beresford IJ; Skingle M; Whalley ET
Ann N Y Acad Sci; 1990; 600():587-98; discussion 598-600. PubMed ID: 2252337
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxytryptamine and the pathophysiology of migraine.
Humphrey PP
J Neurol; 1991; 238 Suppl 1():S38-44. PubMed ID: 2045830
[TBL] [Abstract][Full Text] [Related]
3. Sumatriptan in the treatment of migraine.
Ferrari MD
Neurology; 1993 Jun; 43(6 Suppl 3):S43-7. PubMed ID: 8389011
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine and its role in migraine.
Lance JW
Eur Neurol; 1991; 31(5):279-81. PubMed ID: 1884718
[TBL] [Abstract][Full Text] [Related]
5. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Peroutka SJ
Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
[TBL] [Abstract][Full Text] [Related]
6. The biology of serotonin receptors: focus on migraine pathophysiology and treatment.
Hamel E
Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S2-6. PubMed ID: 10563226
[TBL] [Abstract][Full Text] [Related]
7. From serotonin receptor classification to the antimigraine drug sumatriptan.
Saxena PR; Ferrari MD
Cephalalgia; 1992 Aug; 12(4):187-96. PubMed ID: 1326401
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
Dechant KL; Clissold SP
Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
Blumenfeld A; Gennings C; Cady R
Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
[TBL] [Abstract][Full Text] [Related]
10. Present and future of 5-HT receptor agonists as antimigraine drugs.
Pauwels PJ; John GW
Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathology of migraine].
Goadsby PJ; Lance JW
Rev Prat; 1990 Feb; 40(5):389-93. PubMed ID: 1968676
[TBL] [Abstract][Full Text] [Related]
12. [The role of serotonin in the pathophysiology of migraine].
Szczudlik A
Neurol Neurochir Pol; 1992; Suppl 2():14-27. PubMed ID: 1337765
[TBL] [Abstract][Full Text] [Related]
13. Preclinical studies on the anti-migraine drug, sumatriptan.
Humphrey PP; Feniuk W; Marriott AS; Tanner RJ; Jackson MR; Tucker ML
Eur Neurol; 1991; 31(5):282-90. PubMed ID: 1653134
[TBL] [Abstract][Full Text] [Related]
14. Advances in understanding the pathophysiology of headache.
Silberstein SD
Neurology; 1992 Mar; 42(3 Suppl 2):6-10. PubMed ID: 1557193
[TBL] [Abstract][Full Text] [Related]
15. Triptans. A support to the central link between serotonin and acetylcholine in migraine.
Nicolodi M; Sicuteri F
Adv Exp Med Biol; 1999; 467():183-9. PubMed ID: 10721055
[TBL] [Abstract][Full Text] [Related]
16. Sumatriptan: efficacy and contribution to migraine mechanisms.
Pearce JM
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
[No Abstract] [Full Text] [Related]
17. [Physiopathology of the migraine crisis and its treatment with a 5-HT1-like agonist].
Arch Neurobiol (Madr); 1989; 52(5):254-6. PubMed ID: 2559670
[No Abstract] [Full Text] [Related]
18. [Therapy of migraine with special reference to sumatriptan].
Baumhackl U
Wien Med Wochenschr; 1994; 144(5-6):110-3. PubMed ID: 8053215
[TBL] [Abstract][Full Text] [Related]
19. Migraine management. New approaches focus on serotonin receptors.
DeRaps PK
Adv Nurse Pract; 1999 May; 7(5):51-5. PubMed ID: 10578735
[No Abstract] [Full Text] [Related]
20. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.
den Boer MO; Villalón CM; Heiligers JP; Humphrey PP; Saxena PR
Br J Pharmacol; 1991 Feb; 102(2):323-30. PubMed ID: 1849764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
